New Products

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug made by Celgene for treating the cancer multiple myeloma, the agency said Friday.

The FDA announced the approval of Pomalyst (pomalidomide) for patients whose disease has progressed after treatment with other cancer drugs.

JOHNSON CITY, N.Y. — Pharmacy automation system manufacturer Innovation has appointed Stephen Donohue as divisional VP sales, chain and high volume, the company said Thursday.

Innovation, which makes the PharmASSIST automation system, said Donohue would lead all the company's sales and marketing activity for the retail chain, mail order and central fill markets.

RALEIGH, N.C. — Kerr Drug will use its partnership with PDX and ScriptPro to increase pharmacy productivity by expanding its central fill model, the regional pharmacy chain said Thursday.

Kerr announced the opening of its central fill operation in Raleigh, N.C.

"It's not just about labor savings, inventory reductions and other efficiencies," Kerr CEO Tony Civello said. "These kinds of innovations and use of technologies are critical to remaining a player in the emerging healthcare ecosystem."

ORANGEBURG, N.Y. — PhotoMedex announced today the expansion of in-store availability of its flagship product no!no! Hair to approximately 950 Bed Bath & Beyond stores nationwide. The product launched initially several months ago through a pilot program in just over 100 Bed Bath & Beyond stores and with the success of the pilot launch, PhotoMedex made the decision to push the product into wider release.

ENGLEWOOD CLIFFS, N.J. — Unilever has introduced a new line of Axe brand facial grooming products that includes razors offered under a partnership with Schick and Philips Norelco, the company said Tuesday.

The new Axe co-branded shaving product lines will be available at Walmart and on the retailer's website and includes Axe Schick Razors and the Axe Philips Norelco electric shaver range, featuring a shave-and-groom kit with interchangeable heads.

NORTHVALE, N.J. — The Food and Drug Administration has approved a regulatory approval application from Elite Pharmaceuticals for an opioid painkiller, the drug maker said Wednesday.

Elite announced the FDA approval of its supplemental application for the manufacture and packaging of naltrexone hydrochloride tablets in the 50-mg strength. The company said the approval would allow it to start manufacturing and packaging the drug for its sales and marketing partner, Mikah Pharma, from which it bought rights to the drug in September 2010.

CHICAGO — February is National Hot Breakfast Month, and Jimmy Dean is celebrating with several new items across its breakfast lineup, the company announced today.

The company is adding several new items to both their frozen and refrigerated line of products.

PRINCETON, N.J. — The Food and Drug Administration has approved a generic antibiotic made by Sandoz, the drug maker said Wednesday.

Sandoz, the generics arm of Swiss drug maker Novartis, announced the approval and launch of clindamycin in 5% dextrose in minibag form, the first generic version of Pfizer's Cleocin Phosphate in Dextrose 5%.

Sales of the branded version were $52.2 million in 2012, according to IMS Health.